Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
- Blood Plasma Market, By Product
5.1 Introduction
5.2 Immunoglobulin
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Albumin
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Protease Inhibitors
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Coagulation Factor Concentrates
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Others
5.6.1 Market Overview
5.6.2 Market Size and Forecast
- Blood Plasma Market, By Application
6.1 Introduction
6.2 Hospitals and Clinics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Research Laboratories
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Academic Institutions
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- Blood Plasma Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Blood Plasma, By Product
7.2.2 North America Blood Plasma, By Application
7.3 Europe
7.3.1 Europe Blood Plasma, By Product
7.3.2 Europe Blood Plasma, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Blood Plasma, By Product
7.4.2 Asia-Pacific Blood Plasma, By Application
7.5 Rest of the World
7.5.1 Rest of the World Blood Plasma, By Product
7.5.2 Rest of the World Blood Plasma, By Application
- Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
- Company Profiles
9.1 Baxter International
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 CSL
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Grifols
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Octapharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 ADMA Biologics
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Cerus Corp
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Sanquin
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Shanghai Raas
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 TCS Biosciences
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments